4th Quarter - Amendment
GILBERT'S LLP for MYLAN LABORATORIES INC
Firm
Client
Income
$90,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Feb 9, 2009 | $90,000 | Replaced |
| 4th Quarter - Amendment (this page) | Oct 23, 2009 | $90,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Consumer Issues/Safety/Products CSP
Reform to legislation and regulations affecting pharmaceutical drug approval and marketing
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAWEL BAILEY | — |
| TIM GILBERT | — |
| NATHANIEL BRANDON LIPKUS | — |
Health Issues HCR
Reform to legislation and regulations affecting pharmaceutical drug approval and marketing
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAWEL BAILEY | — |
| TIM GILBERT | — |
| NATHANIEL BRANDON LIPKUS | — |
Pharmacy PHA
Reform to legislation and regulations affecting pharmaceutical drug approval and marketing
| Lobbyist | Covered position, as disclosed |
|---|---|
| NAWEL BAILEY | — |
| TIM GILBERT | — |
| NATHANIEL BRANDON LIPKUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.